Research Articles | Page 84 | Aplastic Anemia & MDS International Foundation Return to top.
  1. Articles
  2. Research Articles

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes Jul 2014 Leuk Res Rep myelodysplastic syndromes (MDS)
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents Dec 2015 Leuk Res. myelodysplastic syndromes (MDS)
Effectiveness of azacitidine in higher-risk myelodysplastic syndromes May 2016 Leukemia myelodysplastic syndromes (MDS)
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents Jan 2013 Leukemia myelodysplastic syndromes (MDS)
Letter to the Editor: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality Jul 2020 Leukemia myelodysplastic syndromes (MDS)
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes Aug 2017 Leukemia
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood - a prospective study by EWOG-MDS. Jun 2013 Leukemia paroxysmal nocturnal hemoglobinuria (PNH)
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes Feb 2018 Leukemia myelodysplastic syndromes (MDS)
Share with addtoany.com.